Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs

Drug Summary of Product Characteristics. Available at: https://cima.aemps.es/cima/publico/lista.html. (Accessed 2019 June 4). Allen, 1977, Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets, Am J Hosp Pharm, 34, 939 Kufel, 2017, Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: do current compatibility testing methodologies tell the whole story?, Hosp Pharm, 52, 132, 10.1310/hpj5202-132 Sautou, 2013 Trissel, 1992, Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection, Am J Hosp Pharm, 49, 1716 Swart EL, van Reij EM, Lee WC, et al. Visual compatibility of atosiban acetate with four drugs. Am J Health Syst Pharm 2005;62(23):2459, 2463. Trissel, 1983, Avoiding common flaws in stability and compatibility studies of injectable drugs, Am J Hosp Pharm, 40, 1159 Staven, 2016, Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs, Nutr J, 22, 29 Physical and physicochemical methods, 2.2.1: clarity and degree of opalescence of liquids. In: European Pharmacopoeia. 7th ed. Strasbourg, Council of Europe; 2010:21–22. United States Pharmacopeia. Physical Tests Chapter 855: nephelometry, turbidimetry, and visual comparison. www.uspnf.com/notices/monographs-affected-by-revision-gc855-mephelometry-turbidimetry-visual-comparison (accessed 12 Jul 2019). Bentley J, Heard K, Collins G et al. Mixing medicines: How to ensure patient safety. Pharmaceut. J 2015. 294(7859). https://www.pharmaceutical-journal.com/download?ac=1068636 (accessed 31 Jul 2019). Newton DW. Crux of drug compatibility and incompatibility. Am J Health Syst Pharm 2010;67(2):108, 112.